Article
Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial
by
Joe Nocera;
Madeleine Hackney;
MariadeLourdes Tansey;
Stewart Factor;
CG Patterson;
E Joslin;
AB Gil;
W Spigle;
T Nemet;
L Chahine;
CL Christiansen;
E Melanson;
WM Kohrt;
M Mancini;
D Josbeno;
K Balfany;
G Griffith;
MK Dunlap;
G Lamotte;
E Suttman;
D Larson;
C Branson;
KE McKee;
L Goelz;
C Poon;
B Tilley;
UJ Kang;
N Luthra;
CM Tanner;
JM Haus;
G Fantuzzi;
NR McFarland;
P Gonzalez-Latapi;
T Foroud;
R Motl;
MA Schwarzschild;
T Simuni;
K Marek;
A Naito;
C Lungu;
DM Corcos;
TD Ellis;
LC Shih;
TJ Nordahl;
MT Stevenson;
JL Alberts;
AK Rao;
C Landis;
EL Stegemoller;
AL Ridgel;
JM Hondzinski;
NM Johannsen;
P Drummond;
H Milton;
DA Hinkle;
FB Horak;
M Afshari;
CP Hurt;
A Kidwell;
C Conroy;
N Panchal;
B Schultz;
J Marchbank;
A Bloemer;
DD Christou;
DE Vaillancourt;
S Lapierre;
CD MacKinnon;
S Amundsen-Huffmaster;
K Garland;
BB Rasmussen;
S Chapman;
J Spahn;
L Wu;
LE Dibble;
GN Olivier;
A Weltman;
WA Dalrymple;
D Edwards;
C Rynders;
L Miller;
GM Earhart;
KS Rawson;
K Jones;
K Nelles;
QJ Almeida;
M Saint-Hilaire;
C Kilbane;
BJ Copeland;
ML Dale;
AJ Espay;
A Ramirez-Zamora;
A Fessenden;
AF Deik;
R Camicioli
2022